Immediate Impact
66 standout
Citing Papers
Lung cancer statistics, 2023
2024 Standout
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
2024 Standout
Works of Emiko Ohki being referenced
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors
2012
Phase I study of TLR9 agonist PF‐3512676 in combination with carboplatin and paclitaxel in patients with advanced non‐small‐cell lung cancer
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Emiko Ohki | 164 | 145 | 67 | 70 | 22 | 316 | |
| Lingling Li | 104 | 72 | 60 | 95 | 28 | 283 | |
| Chang‐Suk Kang | 79 | 40 | 83 | 97 | 27 | 363 | |
| M.B. Atkins | 183 | 84 | 24 | 70 | 22 | 357 | |
| Ajay Bapna | 111 | 74 | 16 | 64 | 36 | 321 | |
| Michael B. Osswald | 63 | 157 | 21 | 26 | 28 | 297 | |
| Eun Suk Kang | 102 | 43 | 37 | 90 | 23 | 354 | |
| Stephen Harnicar | 86 | 56 | 33 | 64 | 17 | 285 | |
| Sanyun Wu | 46 | 29 | 46 | 121 | 20 | 277 | |
| Kriti Mittal | 133 | 132 | 27 | 154 | 28 | 343 | |
| Marco Ligi | 168 | 83 | 98 | 69 | 23 | 358 |
All Works
Loading papers...